Cargando…
Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog
BACKGROUND: Although the new isoxazoline drug fluralaner (Bravecto®) is generally well tolerated in dogs, adverse drug reactions involving neurological dysfunction occurred in individual dogs. However, most of these cases are documented inadequately and none of them is reported and discussed in the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686215/ https://www.ncbi.nlm.nih.gov/pubmed/31391054 http://dx.doi.org/10.1186/s12917-019-2016-4 |